BIO-Europe® 2016: eTheRNA CEO outlines development plan in cancer RNA space

November 22, 2016
Mike Ward, global director of content for Informa Pharma Intelligence, interviews Dirk Reyn, CEO of eTheRNA, on the sidelines of the BIO-Europe® partnering conference in Cologne, Germany. The pair discusses eTheRNA's emerging cancer immunotherapy pipeline, funding prospects and the next steps for the company—which was founded in 2013—as it looks to expand its business.
Previous Video
BIO-Europe® 2016: Cinfa outlines biosimilar development areas and deal opportunities
BIO-Europe® 2016: Cinfa outlines biosimilar development areas and deal opportunities

Cinfa Biotech's managing director, Ruediger Jankowsky, chats with Mike Ward, global director of content for...

Next Video
BIO-Europe® 2016: AiCuris seeks partners for antibacterial programs
BIO-Europe® 2016: AiCuris seeks partners for antibacterial programs

AiCuris CEO Holger Zimmermann talks to Mike Ward, global director of content for Informa Pharma Intelligenc...